C ¹ÝÀÀ¼º ´Ü¹éÁú(CRP) °Ë»ç ½ÃÀå, ½ÃÀå ±âȸ, ¼ºÀå ÃËÁø¿äÀÎ, »ê¾÷ µ¿Ç⠺м®°ú ¿¹Ãø(2024-2032³â)
C-reactive Protein Testing Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032
»óǰÄÚµå : 1570944
¸®¼­Ä¡»ç : Global Market Insights Inc.
¹ßÇàÀÏ : 2024³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 130 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,850 £Ü 7,017,000
PDF & Excel (Single User License) help
PDF, Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,050 £Ü 8,753,000
PDF & Excel (Multi User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,350 £Ü 12,081,000
PDF & Excel (Enterprise User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ CRP(C ¹ÝÀÀ¼º ´Ü¹éÁú) °Ë»ç ½ÃÀåÀº 2023³â¿¡ ¾à 32¾ï ´Þ·¯·Î Æò°¡µÇ¸ç, 2024-2032³â CAGRÀº 3.9%·Î, 2032³â¿¡´Â ¾à 44¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÀÌ ¼ºÀåÀÇ ¿øµ¿·ÂÀº ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ÀÌ·¯ÇÑ ÁúȯÀÇ Áø´Ü ¹× °ü¸®¿¡ ÇʼöÀûÀÎ CRP °Ë»ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù. ·ù¸¶Æ¼½º °üÀý¿°, ½ÉÇ÷°ü Áúȯ, ´ç´¢º´°ú °°Àº ¸¸¼ºÁúȯÀº CRP °Ë»ç·Î ÃËÁøµÇ´Â ÀϰüµÈ ¸ð´ÏÅ͸µ°ú °ü¸®°¡ ÇÊ¿äÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¸¸¼ºÁúȯ Áõ°¡´Â Á¶±â ¹ß°ß°ú Áö¼ÓÀûÀÎ °ü¸®¸¦ À§ÇØ CRP °Ë»ç¿¡ ´ëÇÑ ÀÇÁ¸µµ¸¦ ³ôÀ̰í ÀÖ½À´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO)´Â 2023³â ¸¸¼ºÁúȯÀÌ Àü ¼¼°è »ç¸Á¿øÀÎÀÇ 71%¸¦ Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óÇϰí ÀÖÀ¸¸ç, ÀÌ´Â È¿°úÀûÀÎ Áø´Ü ¹× ¸ð´ÏÅ͸µ ÅøÀÇ ½Ã±ÞÇÑ Çʿ伺À» °­Á¶Çϰí ÀÖ½À´Ï´Ù. ÀÌ¿¡ µû¶ó ¸¸¼ºÁúȯÀÇ ±ÞÁõÀ¸·Î CRP °Ë»ç¿¡ ´ëÇÑ ¼¼°è ¼ö¿ä°¡ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù.

Á¦Ç°º°·Î ºÐ·ùÇϸé CRP(C ¹ÝÀÀ¼º ´Ü¹éÁú) °Ë»ç ½ÃÀå¿¡´Â Àåºñ, ŰƮ ¹× ½Ã¾àÀÌ Æ÷ÇԵǸç, 2023³â¿¡´Â ŰƮ ¹× ½Ã¾à ºÎ¹®ÀÌ ½ÃÀåÀ» ÁÖµµÇÏ¿© 20¾ï ´Þ·¯ÀÇ ¸ÅÃâÀ» ¿Ã·È½À´Ï´Ù. ŰƮ ¹× ½Ã¾àÀº ´Ù¾çÇÑ Àåºñ¿Í Ç÷§Æû¿¡ ÀûÀÀÇÒ ¼ö ÀÖ´Â ´Ù¿ëµµÇÑ Æ¯¼ºÀ» °¡Áö°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀûÀÀ¼ºÀº È¿¼Ò °áÇÕ ¸é¿ª ÈíÂø ÃøÁ¤¹ý, ¸é¿ª ºñħÅõ ÃøÁ¤¹ý, È­ÇÐ ¹ß±¤ ¸é¿ªÃøÁ¤¹ý µî ´Ù¾çÇÑ CRP ÃøÁ¤ ¹æ¹ýÀ» Áö¿øÇÏ¿© ´Ù¾çÇÑ ÀÓ»ó ȯ°æ¿¡¼­ ¸Å·ÂÀ» ³ôÀÔ´Ï´Ù. ¸¹Àº CRP °Ë»ç ŰƮ´Â »ç¿ë ÆíÀǼº°ú ºü¸¥ °á°ú¸¦ ¿ì¼±½ÃÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Æ¯Â¡Àº Àû½Ã ÀÇ»ç°áÁ¤ÀÌ °¡Àå Áß¿äÇÑ ÀÓ»ó ÇöÀå¿¡¼­ ÇʼöÀûÀ̸ç, º¹ÀâÇÏ°í ½Ã°£ÀÌ ¿À·¡ °É¸®´Â ¹æ¹ýº¸´Ù ÀÌ·¯ÇÑ Å°Æ®°¡ ´õ ¸Å·ÂÀûÀ¸·Î ´À²¸Áú ¼ö ÀÖ½À´Ï´Ù.

CRP(C ¹ÝÀÀ¼º ´Ü¹éÁú) °Ë»ç ½ÃÀåÀÇ ÃøÁ¤¹ý À¯Çü¿¡´Â È­Çй߱¤¸é¿ªÃøÁ¤¹ý(CLIA), È¿¼Ò °áÇÕ ¸é¿ª ÈíÂø¹ý(ELISA), ¸é¿ª³óµµ ÃøÁ¤¹ý, ±âŸ µîÀÌ ÀÖ½À´Ï´Ù. ¸é¿ª³óµµ ÃøÁ¤¹ý ºÎ¹®Àº ¿¹Ãø ±â°£ Áß 16¾ï ´Þ·¯ÀÇ ¸ÅÃâÀ» ±â·ÏÇÏ¸ç ½ÃÀåÀ» ÁÖµµÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¸é¿ª³óµµÃøÁ¤¹ýÀº CLIA³ª ELISA¿Í °°Àº °í°¡ÀÇ ¿É¼Ç°ú ºñ±³ÇßÀ» ¶§ ƯÈ÷ Àú·ÅÇÑ ºñ¿ëÀ¸·Î ÀÎÇØ µÎµå·¯Áý´Ï´Ù. ÀÌ·¯ÇÑ ºñ¿ë ÀÌÁ¡Àº ´Ù¾çÇÑ ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ, ƯÈ÷ ¼Ò±Ô¸ð Ŭ¸®´Ð°ú ¿¹»êÀÌ Á¦ÇÑµÈ °Ë»ç ½Ã¼³¿¡ ¾îÇÊÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®Àº ºü¸¥ ó¸® ¼Óµµ¿Í È¿À²¼ºÀ¸·Î ³ôÀº Æò°¡¸¦ ¹Þ°í ÀÖ½À´Ï´Ù.

2023³â ºÏ¹Ì CRP(C ¹ÝÀÀ¼º ´Ü¹éÁú) °Ë»ç ½ÃÀåÀº 12¾ï ´Þ·¯ ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç ÇâÈÄ ¼ö³â°£ Å©°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Áö¿ªÀº ¸¸¼ºÁúȯ, ƯÈ÷ ½ÉÇ÷°ü Áúȯ°ú ´ç´¢º´ÀÇ ³ôÀº À¯º´·ü·Î °íÅë ¹Þ°í ÀÖÀ¸¸ç, CRP ¼öÄ¡ ¸ð´ÏÅ͸µÀº ÀÌ·¯ÇÑ ÁúȯÀÇ ¿°ÁõÀ» Æò°¡Çϱâ À§ÇØ ÀϹÝÀûÀ¸·Î CRP ¼öÄ¡¸¦ ¸ð´ÏÅ͸µÇϹǷΠÀÌ·¯ÇÑ Áõ°¡´Â CRP °Ë»ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ºÏ¹ÌÀÇ Ã·´Ü ÀÇ·á ÀÎÇÁ¶ó¿Í Áø´Ü ±â¼ú¿¡ ´ëÇÑ ±¤¹üÀ§ÇÑ Á¢±Ù¼ºÀº CRP °Ë»ç ½ÃÀåÀ» ´õ¿í Ȱ¼ºÈ­½Ãų °ÍÀÔ´Ï´Ù. ÀÌ Áö¿ªÀÇ Çõ½ÅÀûÀÎ Áø´Ü Åø¿¡ ´ëÇÑ ¼ö¿ë°ú Áúº´ÀÇ Á¶±â ¹ß°ß¿¡ ´ëÇÑ Àû±ØÀûÀΠŵµ´Â CRP °Ë»çÀÇ »ç¿ëÀ» È®´ëÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú Á¶»ç ¹üÀ§

Á¦2Àå °³¿ä

Á¦3Àå ¾÷°è ÀλçÀÌÆ®

Á¦4Àå °æÀï ±¸µµ

Á¦5Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : Á¦Ç°º°, 2021-2032³â

Á¦6Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : ¾î¼¼ÀÌ À¯Çüº°, 2021-2032³â

Á¦7Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : ŽÁö ¹üÀ§º°, 2021-2032³â

Á¦8Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : ¿ëµµº°, 2021-2032³â

Á¦9Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : ÃÖÁ¾ ¿ëµµº°, 2021-2032³â

Á¦10Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : Áö¿ªº°, 2021-2032³â

Á¦11Àå ±â¾÷ °³¿ä

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The Global C-reactive Protein Testing Market was valued at approximately USD 3.2 billion in 2023 and is projected to reach around USD 4.4 billion by 2032, reflecting a CAGR of 3.9% from 2024-2032. This growth is driven by the rising prevalence of chronic disorders and an increasing demand for CRP testing, crucial for diagnosing and managing these conditions. Chronic ailments like rheumatoid arthritis, cardiovascular diseases, and diabetes require consistent monitoring and management, facilitated by CRP testing. The uptick in these chronic conditions has intensified the reliance on CRP tests for early detection and ongoing management. The World Health Organization (WHO) reported in 2023 that chronic diseases accounted for 71% of global deaths, highlighting the urgent need for effective diagnostic and monitoring tools. Consequently, this surge in chronic diseases is propelling the global demand for CRP testing.

The overall C-reactive protein testing industry is classified based on the detection range, product, assay type, application, and region.

Segmented by product, the C-reactive protein testing market includes instruments, kits, and reagents. In 2023, the kits and reagents segment led the market, generating revenues of USD 2 billion. Kits and reagents are versatile and compatible with various instruments and platforms. This adaptability caters to diverse CRP assays, including enzyme-linked immunosorbent assay, immunoturbidimetric assay, and chemiluminescence immunoassay, enhancing their appeal across multiple clinical environments. Many CRP testing kits prioritize user-friendliness and rapid results. Such features are vital in clinical settings where timely decisions are paramount, making these kits more appealing than intricate, time-consuming methods.

Assay types in the C-reactive protein testing market include chemiluminescence immunoassay (CLIA), enzyme-linked immunosorbent assay (ELISA), immunoturbidimetric assay, and others. The immunoturbidimetric assay segment is projected to lead the market with anticipated revenues of USD 1.6 billion during the forecast period. Immunoturbidimetric assays stand out for their affordability, especially compared to pricier options like CLIA and ELISA. This cost advantage appeals to a broad spectrum of healthcare providers, notably smaller clinics and budget-constrained laboratories. These assays are celebrated for their swift processing and efficiency.

In 2023, North America accounted for USD 1.2 billion in the C-reactive protein testing market and is poised for significant growth in the coming years. The region grapples with a high prevalence of chronic diseases, notably cardiovascular ailments and diabetes. This uptick drives the demand for CRP testing, as monitoring CRP levels is common for assessing inflammation in these conditions. North America's advanced healthcare infrastructure and broad access to diagnostic technologies further fuel the CRP testing market. The region's embrace of innovative diagnostic tools and a proactive stance on early disease detection amplify CRP test usage.

Table of Contents

Chapter 1 Methodology and Scope

Chapter 2 Executive Summary

Chapter 3 Industry Insights

Chapter 4 Competitive Landscape, 2023

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

Chapter 6 Market Estimates and Forecast, By Assay Type, 2021 - 2032 ($ Mn)

Chapter 7 Market Estimates and Forecast, By Detection Range, 2021 - 2032 ($ Mn)

Chapter 8 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

Chapter 9 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

Chapter 11 Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â